Some papers indicate that IL-12p70 can also have suppressive effects on allogenic or tumor-specific CTL generation [36, 37], but since evidence undisputedly demonstrates anti-tumor effects for IL-12 its production by tumor cells is possibly just a side product of TLR4 activation and subsequent NF-κB activation. The gene discussed is NFKB1; the disease is neoplasm.